131I-rituximab treatment in patient with relapsed non-Hodgkin's lymphoma: the first case report in Thailand.

Kositwattanarerk, Arpakorn; Changmuang, Wirote; Sangsuriyan, Jatupol; Thongklam, Kittiphong; Sritara, Chanika; Utamakul, Chirawat; Chamroonrat, Wichana; Thamnirat, Kanungnij; Anongpornyochkul, Yoch; Chancharunee, Suporn

Kositwattanarerk, Arpakorn; Changmuang, Wirote; Sangsuriyan, Jatupol; Thongklam, Kittiphong; Sritara, Chanika; Utamakul, Chirawat; Chamroonrat, Wichana; Thamnirat, Kanungnij; Anongpornyochkul, Yoch; Chancharunee, Suporn.

Afiliação

Kositwattanarerk A; Division of Nuclear Medicine, Department of Radiology, Faculty ofMedicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. arpakorn13521@gmail.com

J Med Assoc Thai ; 96(6): 756-60, 2013 Jun.

Article em En | MEDLINE | ID: mdl-23951835

ABSTRACT

ABSTRACT

Radioimmunotherapy (RIT) with 131-rituximab is a safe and effective treatment in patients with relapsed, refractory follicular lymphoma. The authors demonstrated the first case of 131-rituximab treatment in the patient with relapsed non-Hodgkin's lymphoma (NHL) in Thailand. There was no immediate complication after treatment. Impressive treatment response occurred.

Assuntos

Anticorpos Monoclonais Murinos/uso terapêutico; Linfoma não Hodgkin/radioterapia; Radioimunoterapia; Feminino; Humanos; Linfoma não Hodgkin/diagnóstico; Recidiva; Rituximab; Tailândia

Buscar no Google

Imprimir

XML

PubMed Links

Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Radioimunoterapia / Anticorpos Monoclonais Murinos Tipo de estudo: Diagnostic_studies Limite: Female / Humans País como assunto: Asia Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links